271 related articles for article (PubMed ID: 15322730)
1. Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.
Putzhammer A; Schoeler A; Rohrmeier T; Sand P; Hajak G; Eichhammer P
Psychopharmacology (Berl); 2005 Mar; 178(2-3):303-8. PubMed ID: 15322730
[TBL] [Abstract][Full Text] [Related]
2. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).
Eichhammer P; Langguth B; Wiegand R; Kharraz A; Frick U; Hajak G
Psychopharmacology (Berl); 2003 Mar; 166(3):294-7. PubMed ID: 12563545
[TBL] [Abstract][Full Text] [Related]
3. Effects of serotonin transporter promoter polymorphisms on serotonin function.
Smith GS; Lotrich FE; Malhotra AK; Lee AT; Ma Y; Kramer E; Gregersen PK; Eidelberg D; Pollock BG
Neuropsychopharmacology; 2004 Dec; 29(12):2226-34. PubMed ID: 15354180
[TBL] [Abstract][Full Text] [Related]
4. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
5. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression.
Zanardi R; Serretti A; Rossini D; Franchini L; Cusin C; Lattuada E; Dotoli D; Smeraldi E
Biol Psychiatry; 2001 Sep; 50(5):323-30. PubMed ID: 11543734
[TBL] [Abstract][Full Text] [Related]
7. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression.
Pollock BG; Ferrell RE; Mulsant BH; Mazumdar S; Miller M; Sweet RA; Davis S; Kirshner MA; Houck PR; Stack JA; Reynolds CF; Kupfer DJ
Neuropsychopharmacology; 2000 Nov; 23(5):587-90. PubMed ID: 11027924
[TBL] [Abstract][Full Text] [Related]
8. A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder.
Willeit M; Praschak-Rieder N; Neumeister A; Zill P; Leisch F; Stastny J; Hilger E; Thierry N; Konstantinidis A; Winkler D; Fuchs K; Sieghart W; Aschauer H; Ackenheil M; Bondy B; Kasper S
Mol Psychiatry; 2003 Nov; 8(11):942-6. PubMed ID: 14593433
[TBL] [Abstract][Full Text] [Related]
9. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
[TBL] [Abstract][Full Text] [Related]
10. The serotonin transporter promoter polymorphism (5-HTTLPR) affects the relation between antidepressant serum concentrations and effectiveness in major depression.
Dreimüller N; Tadić A; Dragicevic A; Boland K; Bondy B; Lieb K; Laux G; Maier W; Müller MJ; Rao ML; Rietschel M; Röschke J; Zill P; Hiemke C
Pharmacopsychiatry; 2012 May; 45(3):108-13. PubMed ID: 22086748
[TBL] [Abstract][Full Text] [Related]
11. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.
Smits KM; Smits LJ; Schouten JS; Stelma FF; Nelemans P; Prins MH
Mol Psychiatry; 2004 May; 9(5):433-41. PubMed ID: 15037864
[TBL] [Abstract][Full Text] [Related]
12. Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
Weizman A; Weizman R
Pharmacogenomics; 2000 Aug; 1(3):335-41. PubMed ID: 11256582
[TBL] [Abstract][Full Text] [Related]
13. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.
Durham LK; Webb SM; Milos PM; Clary CM; Seymour AB
Psychopharmacology (Berl); 2004 Aug; 174(4):525-9. PubMed ID: 12955294
[TBL] [Abstract][Full Text] [Related]
14. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
[TBL] [Abstract][Full Text] [Related]
15. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers.
Patkar AA; Berrettini WH; Mannelli P; Gopalakrishnan R; Hoehe MR; Bilal L; Weinstein S; Vergare MJ
Psychiatr Genet; 2004 Mar; 14(1):25-32. PubMed ID: 15091312
[TBL] [Abstract][Full Text] [Related]
16. Sequence analysis of the serotonin transporter and associations with antidepressant response.
Kraft JB; Slager SL; McGrath PJ; Hamilton SP
Biol Psychiatry; 2005 Sep; 58(5):374-81. PubMed ID: 15993855
[TBL] [Abstract][Full Text] [Related]
17. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.
Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
J Clin Psychopharmacol; 2003 Dec; 23(6):563-7. PubMed ID: 14624186
[TBL] [Abstract][Full Text] [Related]
18. Alleles of a functional serotonin transporter promoter polymorphism are associated with major depression in alcoholics.
Nellissery M; Feinn RS; Covault J; Gelernter J; Anton RF; Pettinati H; Moak D; Mueller T; Kranzler HR
Alcohol Clin Exp Res; 2003 Sep; 27(9):1402-8. PubMed ID: 14506400
[TBL] [Abstract][Full Text] [Related]
19. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
Strohmaier J; Wüst S; Uher R; Henigsberg N; Mors O; Hauser J; Souery D; Zobel A; Dernovsek MZ; Streit F; Schmäl C; Kozel D; Placentino A; Farmer A; McGuffin P; Aitchison KJ; Rietschel M
World J Biol Psychiatry; 2011 Oct; 12(7):528-38. PubMed ID: 21388237
[TBL] [Abstract][Full Text] [Related]
20. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.
Whale R; Quested DJ; Laver D; Harrison PJ; Cowen PJ
Psychopharmacology (Berl); 2000 May; 150(1):120-2. PubMed ID: 10867985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
